Procter & Gamble Company (The) $PG Position Lifted by Boston Partners

Boston Partners raised its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 373,855 shares of the company’s stock after acquiring an additional 10,399 shares during the period. Boston Partners’ holdings in Procter & Gamble were worth $54,314,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ellis Investment Partners LLC raised its holdings in Procter & Gamble by 0.7% in the third quarter. Ellis Investment Partners LLC now owns 8,816 shares of the company’s stock worth $1,281,000 after buying an additional 64 shares during the last quarter. Clark Wealth Partners lifted its position in Procter & Gamble by 20.6% during the third quarter. Clark Wealth Partners now owns 387 shares of the company’s stock valued at $56,000 after purchasing an additional 66 shares during the last quarter. Kuhn & Co Investment Counsel boosted its stake in Procter & Gamble by 1.0% during the third quarter. Kuhn & Co Investment Counsel now owns 6,555 shares of the company’s stock worth $952,000 after buying an additional 66 shares during the period. BCGM Wealth Management LLC lifted its position in shares of Procter & Gamble by 2.4% during the third quarter. BCGM Wealth Management LLC now owns 2,820 shares of the company’s stock worth $410,000 after purchasing an additional 66 shares during the last quarter. Finally, Whelan Financial increased its holdings in Procter & Gamble by 1.9% during the 3rd quarter. Whelan Financial now owns 3,689 shares of the company’s stock worth $536,000 after purchasing an additional 68 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE:PG opened at $169.31 on Friday. The company’s 50-day moving average is $156.85 and its two-hundred day moving average is $150.40. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $173.59. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. The firm has a market capitalization of $392.42 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 4.25 and a beta of 0.36.

Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The firm had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.99 earnings per share. Analysts forecast that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 16th. Investors of record on Friday, October 23rd were given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.51%.

Insider Activity at Procter & Gamble

In other news, insider Victor Aguilar sold 18,812 shares of the stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $164.43, for a total transaction of $3,093,257.16. Following the sale, the insider owned 55,243 shares of the company’s stock, valued at approximately $9,083,606.49. This represents a 25.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Shailesh Jejurikar sold 35,000 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the transaction, the chief executive officer owned 55,391 shares of the company’s stock, valued at approximately $9,033,718.19. This trade represents a 38.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 193,738 shares of company stock valued at $31,813,782 over the last quarter. 0.23% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently commented on PG. Freedom Broker raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 target price for the company in a research report on Friday, October 23rd. UBS Group set a $166.00 price target on shares of Procter & Gamble in a research report on Friday, October 23rd. Morgan Stanley raised their target price on Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday, October 23rd. Barclays lifted their target price on shares of Procter & Gamble from $152.00 to $165.00 and gave the stock an “equal weight” rating in a research note on Monday, October 26th. Finally, Royal Bank Of Canada set a $169.00 price target on shares of Procter & Gamble in a research report on Friday, October 23rd. Fifteen analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $171.76.

Check Out Our Latest Report on Procter & Gamble

Trending Headlines about Procter & Gamble

Investors following PG have been watching these headlines:

  • Positive Sentiment: P&G is targeting up to $10 billion in productivity savings from fiscal 2027 through 2030, using automation and other efficiencies. The savings target appears to be supporting investor interest, though the company faces rising raw-material, energy and freight costs. P&G savings and workforce plans
  • Positive Sentiment: Citigroup raised its price target to $190 from $187 and maintained a Buy rating, adding a bullish analyst signal. Citigroup rating and target
  • Neutral Sentiment: The company reaffirmed its fiscal 2027 outlook. TD Cowen lifted its price target to $180 but kept a Hold rating, signaling measured expectations. TD Cowen rating and target

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.